A. Acylglycines B. Acylcarnitine C. Amino acids D. Free fatty acids E. Ketone bodies F. Unsure

A. Cardiomyopathy B. Exercise-induced rhabdomyolysis C. Fasting hypoglycemia D. Morbid obesity E. Retinopathy F. Unsure

A. The Atkins diet B. Medium-chain triglycerides C. A ketogenic diet D. Intermittent fasting E. The paleo diet F. Unsure

A. Hyperketotic hyperglycemia B. Hyperketotic hypoglycemia C. Hypoketotic hypoglycemia D. Hypoketotic hyperglycemia E. Ketotic hyperglycinemia F. Unsure

A. Rare diseases are well-defined and include any disease that affects fewer than 500,000 patients in the United States B. There are approximately 7000 rare diseases and fewer than 600 have a Food and Drug Administration (FDA)-approved treatment C. Ultra-rare diseases have fewer than 10,000 patients, as defined by the FDA D. Drug development for rare diseases was spurred by the Rare Disease Drug Act of 1983 E. Unsure

A. Triheptanoin is a synthetic 4-carbon triglyceride B. Patients will take 4 capsules 3 times a day C. The most common side effects are infections D. Triheptanoin should be taken in combination with a low-fat diet E. Unsure